Genetic Variation on TNF/LTA and TNFRSF1A Genes is Associated with Outcomes of Hepatitis C Virus Infection

References

• Baradaran Ghavami S, Seyed Reza SR, Karimi K, Azimzadeh P, Sharifian A, Mojahed Yazdi H, Hatami B. 2018. Variants in two gene members of the TNF ligand superfamily and hepatitis C virus chronic disease. Gastroenterol Hepatol from Bed to Bench. 11(Suppl 1):S66–S72.
   PubMedGoogle Scholar
• Baud V, Karin M. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11(9):372–77.
   PubMed Web of Science ®Google Scholar
• Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO. 2011. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol. 6(5):533–49.
   PubMed Web of Science ®Google Scholar
• Cheng S, Li J, Liu W, Liu C, Liu J. 2015. LTA + 252A > G polymorphism is associated with risk of nasal NK/T-cell lymphoma in a Chinese population: a case-control study. BMC Cancer. 15(1):480.
   PubMedGoogle Scholar
• Corradin O, Scacheri PC. 2014 Oct 28. Enhancer variants: evaluating functions in common disease. Genome Med. 6(10):85. doi:10.1186/s13073-014-0085-3.
   PubMedGoogle Scholar
• Dostert C, Grusdat M, Letellier E, Brenner D. 2019. The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol Rev. 99(1):115–60.
   PubMed Web of Science ®Google Scholar
• Duggal P, Thio CL, Wojcik GL, Goedert JJ, Thomas DL. 2013. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 158(4):235.
   PubMed Web of Science ®Google Scholar
• Esposito S, Bosis S, Orenti A, Spena S, Montinaro V, Bianchini S, Zampiero A, Principi N. 2016. Genetic polymorphisms and the development of invasive bacterial infections in children. Int J Immunopathol Pharmacol. 29(1):99–104.
   PubMed Web of Science ®Google Scholar
• García-Ramírez RA, Ramírez-Venegas A, Quintana-Carrillo R, Camarena ÁE, Falfán-Valencia R, Mejía-Aranguré JM. 2015. TNF, IL6, and IL1B polymorphisms are associated with severe influenza A (H1N1) virus infection in the mexican population. PLoS One. 10:e0144832.
   PubMed Web of Science ®Google Scholar
• Getachew Y, Browning JD, Prebis M, Rogers T, Brown GR. 2004. Combination therapy for the treatment of hepatitis C in the veteran population: higher than expected rates of therapy discontinuation. Aliment Pharmacol Ther. 20:629–36.
   PubMed Web of Science ®Google Scholar
• Grebely J, Dore GJ, Kim AY, Lloyd A, Shoukry NH, Prins M, Page K. 2015. Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn. Hepatology. 60(6):2127–28.
   Web of Science ®Google Scholar
• Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F, Poschmann G, Kaur G, Lambert L, Leach OA. 2012. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature. 488(7412):508–11.
   PubMed Web of Science ®Google Scholar
• Huang P, Dong L, Lu X, Zhang Y, Chen H, Wang J, Zhang Y, Su J, Yu R. 2014 Dec 21. Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study. BMC Infect Dis. 14(1):716. doi:10.1186/s12879-014-0716-8.
   PubMedGoogle Scholar
• Huang Y, Yu X, Wang L, Zhou S, Sun J, Feng N, Nie S, Wu J, Gao F, Fei B, et al. 2013. Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis. PLoS One. 8(12):e82519.
   PubMed Web of Science ®Google Scholar
• Kamal SM, Kassim SK, Ahmed AI, Mahmoud S, Bahnasy KA, Hafez TA, Aziz IA, Fathelbab IF, Mansour HM. 2014. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study. Am J Gastroenterol. 109(2):199–211.
   PubMed Web of Science ®Google Scholar
• Laddha NC, Dwivedi M, Gani AR, Mansuri MS, Begum R, Srinivas M. 2013. Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility. PLoS One. 8(11):e81736.
   PubMed Web of Science ®Google Scholar
• Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. 1996. Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C. Hepatology. 23(2):210–17.
   PubMed Web of Science ®Google Scholar
• Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW, McKnight B, Malone KE. 2011. Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer. Breast Cancer Res Treat. 129(3):887–99.
   PubMed Web of Science ®Google Scholar
• Miao Z, Zhenrong X, Jing M, Jieyu R, Yue F, Xueshan X. 2017. Regulated entry of hepatitis C virus into hepatocytes. Viruses. 9(5):100.
   PubMed Web of Science ®Google Scholar
• Mira JP. 1999. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. Jama J Am Med Assoc. 282(6):561–68.
   PubMed Web of Science ®Google Scholar
• Organization, W.H. 2017. Global hepatitis report 2017. Geneva (Switzerland): World Health Organization.
   Google Scholar
• Organization, W.H. 2018. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva (Switzerland): World Health Organization.
   Google Scholar
• Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y. 2002. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet. 32(4):650.
   PubMed Web of Science ®Google Scholar
• Park TJ, Kim HJ, Kim JH, Bae JS, Cheong HS, Park BL, Shin HD. 2013. Associations of CD6, TNFRSF1A and IRF8 polymorphisms with risk of inflammatory demyelinating diseases. Neuropathol Appl Neurobiol. 39(5):519–30.
   PubMed Web of Science ®Google Scholar
• Pompili M, Biolato M, Miele L, Grieco A. 2013. Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review. 世界胃肠病学杂志:英文版 (电子版). 19(44):7867–73.
   Google Scholar
• Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R. 2006. Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J Virol. 80(9):4372–79.
   PubMed Web of Science ®Google Scholar
• Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, Stayoussef M, Yacoubi-Loueslati B. 2015. The relationship between TNF alpha gene polymorphisms (?238/?308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene. 568(2):140–45.
   PubMed Web of Science ®Google Scholar
• Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, et al. 2019. Direct-acting antiviral therapy for HCV infection is associated with increased survival in patients with a history of hepatocellular carcinoma. Gastroenterology. 157(5):1253–63.
   Google Scholar
• Sung PS, Racanelli V, Shin EC. 2014. CD8(+) T-cell responses in acute hepatitis C virus infection. Front Immunol. 5:266.
   PubMed Web of Science ®Google Scholar
• Tan JH, Temple SEL, Kee C, Waterer GW, Tan CRT, Gut I, Price P. 2011. Characterisation of TNF block haplotypes affecting the production of TNF and LTA. Tissue Antigens. 77(2):100–06.
   PubMedGoogle Scholar
• Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Huber C. 1992. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 103(1):264.
   PubMed Web of Science ®Google Scholar
• Vielhauer V, Mayadas TN. 2007. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol. 27(3):286–308.
   PubMed Web of Science ®Google Scholar
• Wadley AL, Hendry LM, Kamerman PR, Chew CS, Price P, Cherry CL, Lombard Z. 2015. Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans. Eur J Hum Genet: EJHG. 23(3):363–68.
   PubMed Web of Science ®Google Scholar
• Ward T, Gordon J, Jones B, Bennett H, Mcewan P. 2016. Value of sustained virologic response in patients with hepatitis C as a function of time to progression of end-stage liver disease. Clin Drug Investig. 37:1–10.
   Web of Science ®Google Scholar
• Waschke KA, Villani A-C, Vermeire S, Dufresne L, Chen T-C, Bitton A, Cohen A, Thomson ABR, Wild GE. 2005. Tumor necrosis factor receptor gene polymorphisms in Crohn\”s disease: association with clinical phenotypes. Am J Gastroenterol. 100(5):1126–33.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Wells F, Major ME. 2010. Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase. J Viral Hepat. 17(4):245–53.
   PubMed Web of Science ®Google Scholar
• Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ. 2000. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun. 1(6):386–90.
   PubMed Web of Science ®Google Scholar